EUVIMEDEUVIMED entdecken
Crossref

Engineering Escherichia coli Nissle 1917 Carrying PD1 Agonists Resolves Intestinal Inflammation via Local Immune Modulation

Mengyuan Hu, Tingting Li, Mengmeng Xu, Anqi Dong iD, Chonghai Zhang, Lei Wang, Wenhao Shen, Yang He, Kai Yang iD, Lin Hu iD

ACS Applied Materials & Interfaces · 18.06.2025 · 17 (24) · 35099-35115

DOI: 10.1021/acsami.5c04339 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 09.05.2025. Verfasst von Mengyuan Hu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The First Affiliated Hospital, State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and P…. Hauptthemen laut MEDLINE: Escherichia coli, Programmed Cell Death 1 Receptor, Probiotics, Colitis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Priority Academic Program Development of Jiangsu Higher Education Institutions, Key Research and Development Program of Social Development of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunological imbalance is a key factor in the progression of intestinal inflammation, yet effective treatments remain elusive. Using a radiation-induced intestinal injury model, we investigated the causes of inflammation at the single-cell level and identified abnormal T-cell activation as a major contributor. To address this, we targeted the PD1 signaling pathway to suppress T-cell activation and evaluated the anti-inflammatory and intestinal repair effects of the PD1 agonist displaying probiotic Escherichia coli Nissle 1917 (EcNMP1-M) in two mouse models. Encapsulated in Eudragit L100-55 for pH-dependent release, EcNMP1-M and its bacterial outer membrane vesicles (OMVs) expressed PD1 agonists, which inhibited excessive immune activation and reduced inflammatory cytokines. EcNMP1-M promoted the expression of proteins that maintain intestinal epithelial barrier integrity, improving gut function and immune responses in colitis mice. Furthermore, 16S rDNA microbiome sequencing revealed that EcNMP1-M enhanced intestinal microbiota diversity, increased beneficial bacteria, and reduced harmful bacteria. This study proposes a localized EcN-based immunosuppressive therapy for radiation-induced enteritis and inflammatory bowel disease with promising potential for clinical applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Escherichia coliProgrammed Cell Death 1 ReceptorProbioticsColitisAnimalsMiceGastrointestinal MicrobiomeMice, Inbred C57BLInflammationIntestinesDisease Models, Animal

Stichwörter der Autor:innen

Escherichia coli Nissle 1917PD1 agonistsinflammatory bowel diseaseouter membrane vesiclesradiation enteritis

Substanzen

Programmed Cell Death 1 ReceptorPdcd1 protein, mouse

Autor:innen und Institutionen

  • Department of Pathology, The First Affiliated Hospital, State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection& School for Radiological and Interdisciplinary Sciences (RAD…
  • Department of Pathology, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China.
  • Department of Oncology, Taizhou People's Hospital Affiliated to Nanjing Medical University, Taizhou, Jiangsu 225300, China.
  • School of Pharmacy, Chengdu University, Chengdu, Sichuan 610106, China.

ORCID-Profile: Anqi Dong, Kai Yang, Lin Hu

Förderung

  • National Natural Science Foundation of China
  • Priority Academic Program Development of Jiangsu Higher Education Institutions
  • Key Research and Development Program of Social Development of Jiangsu Province
  • Key Laboratory of Radiation Damage and Treatment of Jiangsu Provincial Universities and Colleges
  • Suzhou Fundamental Research Project

Zitieren

APA

Hu, M., Li, T., Xu, M., Dong, A., Zhang, C., Wang, L., Shen, W., He, Y., Yang, K., & Hu, L. (2025). Engineering Escherichia coli Nissle 1917 Carrying PD1 Agonists Resolves Intestinal Inflammation via Local Immune Modulation. ACS Applied Materials & Interfaces, 17(24), 35099-35115. https://doi.org/10.1021/acsami.5c04339

Vancouver

Hu M, Li T, Xu M, Dong A, Zhang C, Wang L, et al. Engineering Escherichia coli Nissle 1917 Carrying PD1 Agonists Resolves Intestinal Inflammation via Local Immune Modulation. ACS Applied Materials & Interfaces. 2025;17(24):35099-35115. doi:10.1021/acsami.5c04339

BibTeX
@article{Hu2025,
  author = {Hu, Mengyuan and Li, Tingting and Xu, Mengmeng and Dong, Anqi and Zhang, Chonghai and Wang, Lei and Shen, Wenhao and He, Yang and Yang, Kai and Hu, Lin},
  title = {Engineering Escherichia coli Nissle 1917 Carrying PD1 Agonists Resolves Intestinal Inflammation via Local Immune Modulation},
  journal = {ACS Applied Materials & Interfaces},
  year = {2025},
  volume = {17},
  number = {24},
  pages = {35099--35115},
  doi = {10.1021/acsami.5c04339}
}
Kostenlos starten →